GRI Bio (GRI) EBT (QoQ) (2020 - 2026)
GRI Bio (GRI) EBT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | GRI Bio | 3.07 Mn | 3.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.14% |
| Dec 31, 2025 | -551.54% |
| Sep 30, 2025 | -19.81% |
| Jun 30, 2025 | 5.05% |
| Mar 31, 2025 | 83.63% |
| Dec 31, 2024 | -775.02% |
| Sep 30, 2024 | 5.63% |
| Jun 30, 2024 | -19.10% |
| Mar 31, 2024 | 88.55% |
| Dec 31, 2023 | -578.43% |
| Sep 30, 2023 | 58.90% |
| Jun 30, 2023 | -500.61% |
| Mar 31, 2023 | 80.86% |
| Dec 31, 2022 | -2,660.96% |
| Sep 30, 2022 | 1.06% |
| Jun 30, 2022 | 92.85% |
| Mar 31, 2022 | 73.83% |
| Dec 31, 2021 | -704.54% |
| Sep 30, 2021 | 45.63% |
| Jun 30, 2021 | 24.56% |